Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Weston

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Aob PLANTS|April 6, 2012
Reductions in biomass accumulation, photosynthesis in situ and net carbon balance are the costs of protecting Vitis vinifera 'Semillon' grapevines from heat stress with shade coveringDennis H Greer, Mark M Weedon, Chris Weston
Environmental Management|May 28, 2005
Measuring and incorporating vulnerability into conservation planningKerrie Wilson, Robert L Pressey, Adrian Newton, et al.
Annals of the New York Academy of Sciences|October 4, 2007
Vascular adhesion protein-1 as a potential therapeutic target in liver diseasePatricia F Lalor, Ceren Tuncer, Chris Weston, et al.
Journal of Pharmaceutical Sciences|September 2, 2003
Indexing powder patterns in physical form screening: instrumentation and data qualityAlastair J Florence, Bruno Baumgartner, Chris Weston, et al.
Annals of Hepato-Biliary-Pancreatic Surgery|May 31, 2021
Role of liver support systems in the management of post hepatectomy liver failure: A systematic review of the literatureKamil Pufal, Alexander Lawson, James Hodson, et al.
BMJ Open|July 5, 2017
Investigating the safety and activity of the use of BTT1023 (Timolumab), in the treatment of patients with primary sclerosing cholangitis (BUTEO): A single-arm, two-stage, open-label, multi-centre, phase II clinical trial protocolKatherine Arndtz, Margaret Corrigan, Anna Rowe, et al.
Journal of the American Heart Association|March 28, 2020
Clinical Potential of Targeting Fibroblast Growth Factor-23 and αKlotho in the Treatment of Uremic CardiomyopathyJonathan P Law, Anna M Price, Luke Pickup, et al.
BMJ Open|January 6, 2025
FAecal micRobiota transplantation in primary sclerosinG chOlangitis (FARGO): study protocol for a randomised, multicentre, phase IIa, placebo-controlled trialSarah Al-Shakhshir, Mohammed Nabil Quraishi, Benjamin Mullish, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Aob PLANTS|April 6, 2012
Reductions in biomass accumulation, photosynthesis in situ and net carbon balance are the costs of protecting Vitis vinifera 'Semillon' grapevines from heat stress with shade coveringDennis H Greer, Mark M Weedon, Chris Weston
Environmental Management|May 28, 2005
Measuring and incorporating vulnerability into conservation planningKerrie Wilson, Robert L Pressey, Adrian Newton, et al.
Annals of the New York Academy of Sciences|October 4, 2007
Vascular adhesion protein-1 as a potential therapeutic target in liver diseasePatricia F Lalor, Ceren Tuncer, Chris Weston, et al.
Journal of Pharmaceutical Sciences|September 2, 2003
Indexing powder patterns in physical form screening: instrumentation and data qualityAlastair J Florence, Bruno Baumgartner, Chris Weston, et al.
Annals of Hepato-Biliary-Pancreatic Surgery|May 31, 2021
Role of liver support systems in the management of post hepatectomy liver failure: A systematic review of the literatureKamil Pufal, Alexander Lawson, James Hodson, et al.
BMJ Open|July 5, 2017
Investigating the safety and activity of the use of BTT1023 (Timolumab), in the treatment of patients with primary sclerosing cholangitis (BUTEO): A single-arm, two-stage, open-label, multi-centre, phase II clinical trial protocolKatherine Arndtz, Margaret Corrigan, Anna Rowe, et al.
Journal of the American Heart Association|March 28, 2020
Clinical Potential of Targeting Fibroblast Growth Factor-23 and αKlotho in the Treatment of Uremic CardiomyopathyJonathan P Law, Anna M Price, Luke Pickup, et al.
BMJ Open|January 6, 2025
FAecal micRobiota transplantation in primary sclerosinG chOlangitis (FARGO): study protocol for a randomised, multicentre, phase IIa, placebo-controlled trialSarah Al-Shakhshir, Mohammed Nabil Quraishi, Benjamin Mullish, et al.
Pageof 1